Brown’s relationship with Hyundai Motor Group is quickly becoming a model for University-Industry partnerships that deepen understandings between scientists, and expands Hyundai’s investment in Brown over time. We completed the Hyundai Visionary Challenge last fall, and have funded four pilot research projects ($50,000) for Drs. Kenny Breuer and Sharon Swartz, David Sheinberg, Stefanie Tellex and William Warren. These teams will present at the Hyundai Mobility Innovator’s Forum in San Francisco in November. The next phase will be announced later this fall (roughly $200,000 for four projects for 1 year, with potential for additional year).
The Brown Biomedical Idea to Impact fund, run by Karen Bulock, announced five awards ($100,000 each) for biomedical innovations originating at Brown this past July. A new cycle will start this fall. BBII will host the Boston Biomedical Innovation Center (B-BIC), an NHLBI funded accelerator, to give three half-day workshops on Pitching, Slide Design, and Healthcare Market Research on October 11, 15, and 16 at Brown. Contact Karen for more information.
Oct 4, 2017 - Amazon.com, Inc. AMZN has acquired Body Labs, a startup that develops AI, computer vision and body-modelling based 3D body shapes and motion for various industries.
January 4, 2017 | Founded on technology licensed from Brown, Medley Genomics is the first company to focus on genomic heterogeneity to provide personalized treatment regimens for individuals based on their unique mutations.
July 11, 2016 | After researchers spent several years developing an artificial intelligence technology to monitor lab animal behavior, a team of recently graduated entrepreneurs is investigating its commercial potential.
April 29, 2016 | Read this Providence Business News article on the company's exciting new medical field called Vasculomics.
January 31, 2016 | Body Labs cofounder Eric Rachlin explores the ways that new smart phones equipped with depth sensors could disrupt several major markets before the year is over including fashion and apparel, mapping and navigation, virtual reality and 3D printing.
January 7, 2016 | Takeda and NsGene announced a research partnership to focus on developing encapsulated cell therapies, an experimental technology that originated at Brown University, for the potential treatment of Parkinson’s disease.
November 3, 2015 | Body Labs, founded in 2013 on technology originating at Brown University and provider of some of the world's most advanced technology for analyzing the human body's shape, pose and motion, today announced it has raised $8 Million in Series A funding -- led by Intel Capital.
Neon Awarded as Technology Pioneer by World Economic Forum
Tivorsan Pharmaceuticals to Present at Biotech Showcase 2015 on Monday, January 12
Blackrock Microsystems Launches Wireless Brain Research System
Today, Blackrock Microsystems LLC announced that it has struck an agreement with Brown University to license and commercialize a wireless neural activity monitoring system that will liberate neuroscientists from the cumbersome wires and cables that have burdened their research for decades.
Industry Engagement and Commercial Venturing (IECV)
The mission of IECV is to unleash the impact of Brown's research by encouraging and facilitating the evolution of Brown's discoveries and inventions into know-how, products and services with societal and economic value.
IECV supports this mission through its three programmatic pillars: (1) Commercial Venturing: we partner with Brown researchers to ascertain the market relevance of their discoveries, then forge the best strategy for transitioning from idea to impact and protecting intellectual property as appropriate in support of lab-to-market development plans; (2) Industry Engagement: we build strategic relationships with industry centered around research collaborations aimed at spawning innovations of commercial interest to our company partners - while also connecting the companies to Brown faculty and researchers, students, entrepreneurs, and executive education programs; and (3) Translational Development: we provide and manage translational development capabilities to help solidify proof of technical feasibility and of commercial relevance, both of which can de-risk an idea or discovery and turn it into more concrete product opportunities that are attractive to potential industry partners or startup creators.
For more information, please contact the Office of Industry Engagement and Commercial Venturing at [email protected] .